文献速递慢阻肺

深度学习从吸气相胸部CT估算小气道病:COPD中的临床验证、可重复性及不良结局关联

Deep Learning Estimation of Small Airway Disease from Inspiratory Chest Computed Tomography: Clinical Validation, Repeatability, and Associations with Adverse Clinical Outcomes in Chronic Obstructive Pulmonary Disease.
PubMed 文献 · Am J Respir Crit Care Med · 2025-01-01

本研究基于SPIROMICS队列2513例参与者开发生成模型,从吸气相胸部CT估算功能性小气道病(fSADTLC),并与双容积参数反应映射fSAD(fSADPRM)比较。结果显示fSADTLC与fSADPRM强相关(SPIROMICS R=0.895,COPDGene R=0.897),与肺功能、生活质量及FEV1年下降相关,且重复测量一致性更高(ICC 0.99 vs 0.83)。

要点

  • AI可从单次吸气相CT估算fSAD,与双容积PRM法强相关。
  • fSADTLC升高与更低FEV1、FEV1/FVC及更差生活质量独立相关。
  • fSADTLC每增1%,FEV1年下降SPIROMICS为1.156 ml、COPDGene为0.866 ml。

核心结论

  • 基于生成式AI可从单次吸气相CT可靠评估小气道病,无需额外呼气相CT。
  • fSADTLC与fSADPRM强相关,与FEV1下降显著关联,且重复性更优。

研究设计与样本

  • 分析SPIROMICS队列2513例参与者,随机抽取1055例开发生成模型,其余1458例用于估算fSADTLC。
  • 在COPDGene研究458例子集中验证结果。
  • 多变量模型调整年龄、种族、性别、BMI、基线FEV1、吸烟包年、吸烟状态及肺气肿百分比。

主要发现

  • fSADTLC与fSADPRM的Pearson R在SPIROMICS为0.895,在COPDGene为0.897。
  • fSADTLC升高与更低支扩后FEV1(升)及FEV1/FVC、更高圣乔治呼吸问卷总分独立相关。
  • SPIROMICS中fSADTLC每增1%,FEV1年下降1.156 ml(95%CI 0.613-1.699;P<0.001)。
  • COPDGene中fSADTLC每增1%,FEV1年下降0.866 ml(95%CI 0.345-1.386;P<0.001)。
  • fSADTLC重复测量ICC为0.99(95%CI 0.98-0.99),fSADPRM为0.83(95%CI 0.76-0.88)。

关键数值与推荐

  • fSADTLC与fSADPRM强相关:SPIROMICS R=0.895,COPDGene R=0.897。
  • fSADTLC每增1%对应FEV1年下降:SPIROMICS 1.156 ml(95%CI 0.613-1.699;P<0.001),COPDGene 0.866 ml(95%CI 0.345-1.386;P<0.001)。
  • 重复测量ICC:fSADTLC 0.99(95%CI 0.98-0.99),fSADPRM 0.83(95%CI 0.76-0.88)。

临床怎么用

  • 可利用单次吸气相胸部CT的AI模型评估小气道病,减少额外呼气相扫描。
  • fSADTLC可作为COPD患者肺功能下降及生活质量损害的影像学关联指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Quantifying functional small airway disease (fSAD) requires additional expiratory computed tomography (CT) scans, limiting clinical applicability. Artificial intelligence (AI) could enable fSAD quantification from chest CT scans at total lung capacity (TLC) alone (fSADTLC). Objectives: To evaluate an AI model for estimating fSADTLC, compare it with dual-volume parametric response mapping fSAD (fSADPRM), and assess its clinical associations and repeatability in chronic obstructive pulmonary disease (COPD). Methods: We analyzed 2,513 participants from SPIROMICS (the Subpopulations and Intermediate Outcome Measures in COPD Study). Using a randomly sampled subset (n = 1,055), we developed a generative model to produce virtual expiratory CT scans for estimating fSADTLC in the remaining 1,458 SPIROMICS participants. We compared fSADTLC with dual-volume fSADPRM. We investigated univariate and multivariable associations of fSADTLC with FEV1, FEV1/FVC ratio, 6-minute-walk distance, St. George's Respiratory Questionnaire score, and FEV1 decline. The results were validated in a subset of patients from the COPDGene (Genetic Epidemiology of COPD) study (n = 458). Multivariable models were adjusted for age, race, sex, body mass index, baseline FEV1, smoking pack-years, smoking status, and percent emphysema. Measurements and Main Results: Inspiratory fSADTLC showed a strong correlation with fSADPRM in SPIROMICS (Pearson's R = 0.895) and COPDGene (R = 0.897) cohorts. Higher fSADTLC levels were significantly associated with lower lung function, including lower postbronchodilator FEV1 (in liters) and FEV1/FVC ratio, and poorer quality of life reflected by higher total St. George's Respiratory Questionnaire scores independent of percent CT emphysema. In SPIROMICS, individuals with higher fSADTLC experienced an annual decline in FEV1 of 1.156 ml (relative decrease; 95% confidence interval [CI], 0.613-1.699; P < 0.001) per year for every 1% increase in fSADTLC. The rate of decline in the COPDGene cohort was slightly lower at 0.866 ml/yr (relative decrease; 95% CI, 0.345-1.386; P < 0.001) per 1% increase in fSADTLC. Inspiratory fSADTLC demonstrated greater consistency between repeated measurements, with a higher intraclass correlation coefficient of 0.99 (95% CI, 0.98-0.99) compared with fSADPRM (0.83; 95% CI, 0.76-0.88). Conclusions: Small airway disease can be reliably assessed from a single inspiratory CT scan using generative AI, eliminating the need for an additional expiratory CT scan. fSAD estimation from inspiratory CT correlates strongly with fSADPRM, demonstrates a significant association with FEV1 decline, and offers greater repeatability.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Chaudhary MFA, Awan HA, Gerard SE, et al. Deep Learning Estimation of Small Airway Disease from Inspiratory Chest Computed Tomography: Clinical Validation, Repeatability, and Associations with Adverse Clinical Outcomes in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2025. PMID: 40072247. doi:10.1164/rccm.202409-1847OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。